Fuan
300194.SZFuan Pharmaceutical (Group) Co., Ltd. Price (300194.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,220,364,028
(2.5764)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Fuan Pharmaceutical (Group) Co., Ltd.Currency: CNY
| YEAR | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
93,440,606.00
+0% |
198,457,058.00
+112% |
324,528,285.00
+64% |
464,010,492.00
+43% |
358,548,287.00
-23% |
420,017,314.00
+17% |
357,779,550.00
-15% |
448,569,652.00
+25% |
708,096,042.00
+58% |
1,297,016,910.00
+83% |
2,090,806,849.00
+61% |
2,669,296,082.00
+28% |
2,780,740,647.00
+4% |
2,368,343,296.00
-15% |
2,453,144,920.00
+4% |
2,421,742,292.00
-1% |
2,647,752,954.00
+9% |
||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 72,696,863.00 | 112,929,082.00 | 167,240,310.00 | 248,378,011.00 | 215,259,384.00 | 269,413,341.00 | 241,332,801.00 | 305,790,269.00 | 395,122,644.00 | 688,439,298.00 | 911,413,056.00 | 1,023,023,736.00 | 1,008,394,750.00 | 819,522,963.00 | 911,465,897.00 | 1,008,187,216.00 | 1,234,788,737.00 | ||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
20,743,743.00
+0% |
85,527,976.00
+312% |
157,287,975.00
+84% |
215,632,481.00
+37% |
143,288,903.00
-34% |
150,603,973.00
+5% |
116,446,749.00
-23% |
142,779,383.00
+23% |
312,973,398.00
+119% |
608,577,612.00
+94% |
1,179,393,793.00
+94% |
1,646,272,346.00
+40% |
1,772,345,897.00
+8% |
1,548,820,333.00
-13% |
1,541,679,023.00
0% |
1,413,555,076.00
-8% |
1,412,964,217.00
0% |
||
| Gross Profit Ratio | (0.22%) | (0.43%) | (0.48%) | (0.46%) | (0.40%) | (0.36%) | (0.33%) | (0.32%) | (0.44%) | (0.47%) | (0.56%) | (0.62%) | (0.64%) | (0.65%) | (0.63%) | (0.58%) | (0.53%) | ||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 1,282,600.00 | 1,853,937.00 | 6,195,200.00 | 8,126,442.00 | 4,890,103.00 | 10,480,294.00 | 11,484,556.00 | 8,833,299.00 | 17,814,223.00 | 52,412,611.00 | 96,637,576.00 | 119,760,731.00 | 108,022,179.00 | 86,944,092.00 | 120,383,270.00 | 142,894,636.00 | 148,786,748.00 | ||
| General and Administrative | 2,326,391.00 | 6,632,816.00 | 10,951,501.00 | 10,247,755.00 | 12,948,169.00 | 19,894,601.00 | 19,769,753.00 | 20,698,656.00 | 28,932,747.00 | 31,387,789.00 | 39,847,964.00 | 39,253,790.00 | 43,592,050.00 | 51,756,755.00 | 49,271,069.00 | 61,742,913.00 | 66,575,824.00 | ||
| Selling, General & Admin... | 5,638,140.00 | 14,319,883.00 | 24,220,628.00 | 27,037,624.00 | 27,372,895.00 | 37,098,597.00 | 41,627,976.00 | 47,281,865.00 | 147,282,168.00 | 171,552,600.00 | 623,049,069.00 | 1,107,152,238.00 | 1,255,298,045.00 | 1,119,010,016.00 | 1,071,050,449.00 | 942,812,151.00 | 820,375,227.00 | ||
| Selling & Marketing Exp... | 3,311,748.00 | 7,687,066.00 | 13,269,127.00 | 16,789,869.00 | 14,424,725.00 | 17,203,996.00 | 21,858,222.00 | 26,583,209.00 | 118,349,421.00 | 140,164,810.00 | 583,201,105.00 | 1,067,898,448.00 | 1,211,705,994.00 | 1,067,253,261.00 | 1,021,779,380.00 | 881,069,237.00 | 753,799,403.00 | ||
| Depreciation and Amortiz... | 2,870,188.00 | 6,072,866.00 | 9,825,527.00 | 12,043,726.00 | 16,331,063.00 | 28,549,055.00 | 34,303,916.00 | 46,169,564.00 | 85,146,601.00 | 121,331,871.00 | 149,826,371.00 | 142,483,667.00 | 145,269,648.00 | 156,474,025.00 | 211,698,311.00 | 185,399,267.00 | 209,786,600.00 | ||
| Other Expenses | -41,524.00 | -82,310.56 | 4,366,447.00 | 970,858.00 | 4,204,358.00 | 8,136,705.00 | 3,918,718.00 | 2,634,755.00 | 4,547,220.00 | 6,137,416.00 | 4,714,603.00 | -1,516,095.48 | 181,004.00 | 351,986.00 | -986,838.89 | 10,827,127.00 | 145,312,869.00 | ||
| Total Operating Expenses | 10,877,481.00 | 26,444,912.00 | 51,482,517.00 | 67,869,830.00 | 60,660,446.00 | 86,818,291.00 | 96,939,241.00 | 107,935,112.00 | 242,322,899.00 | 343,799,047.00 | 859,182,006.00 | 1,373,957,717.00 | 1,493,115,748.00 | 1,346,414,369.00 | 1,345,742,134.00 | 1,246,474,581.00 | 1,114,474,845.00 | ||
| Cost and Exponses | 83,574,345.00 | 139,373,995.00 | 218,722,828.00 | 316,247,842.00 | 275,919,831.00 | 356,231,633.00 | 338,272,043.00 | 413,725,381.00 | 637,445,543.00 | 1,032,238,346.00 | 1,770,595,063.00 | 2,396,981,454.00 | 2,501,510,499.00 | 2,165,937,333.00 | 2,257,208,031.00 | 2,254,661,798.00 | 2,349,263,583.00 | ||
| Operating Income | |||||||||||||||||||
| Operating Income |
5,952,643.00
+0% |
54,224,559.00
+811% |
105,423,285.00
+94% |
145,469,522.00
+38% |
111,300,689.00
-23% |
98,282,844.00
-12% |
43,277,625.00
-56% |
53,804,345.00
+24% |
77,958,751.00
+45% |
255,760,107.00
+228% |
329,173,956.00
+29% |
-321,142,640.95
-198% |
326,593,239.00
-202% |
240,771,511.00
-26% |
-590,998,569.16
-345% |
178,525,372.00
-130% |
298,489,370.00
+67% |
||
| Operating Income Ratio | (0.06%) | (0.27%) | (0.32%) | (0.31%) | (0.31%) | (0.23%) | (0.12%) | (0.12%) | (0.11%) | (0.20%) | (0.16%) | (-0.12%) | (0.12%) | (0.10%) | (-0.24%) | (0.07%) | (0.11%) | ||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | -0.50 | 74,345.00 | 1,442,270.00 | 311,655.00 | 28,969,755.00 | 36,139,114.00 | 26,432,677.00 | 20,839,155.00 | 7,584,851.00 | 3,056,279.00 | 2,075,987.00 | 9,289,543.00 | 19,375,910.00 | 17,065,603.00 | 22,734,984.00 | 28,323,407.00 | 32,015,299.00 | ||
| Interest Expenses | 3,379,567.00 | 2,863,837.00 | 3,441,897.00 | 1,668,307.00 | 499,885.00 | 433,128.00 | 923,333.00 | 415,333.00 | 7,002,145.00 | 12,654,385.00 | 1,194,337.00 | 1,545,687.00 | 2,403,766.00 | 10,162,479.00 | 20,448,171.00 | 26,937,881.00 | 30,392,004.00 | ||
| Total Other Income/Exp... | -44,607.00 | -2,934,789.00 | 3,573,457.00 | 404,590.00 | 30,716,416.00 | 42,453,517.00 | 939,689.00 | 190,564.00 | -1,586,034.00 | 1,571,618.00 | 4,714,609.00 | -1,516,091.00 | 181,008.00 | 351,989.00 | -986,836.00 | 10,827,127.00 | -8,131,581.00 | ||
| EBITDA | |||||||||||||||||||
| EBITDA | 12,736,450.00 | 63,015,937.00 | 122,264,170.00 | 159,586,086.00 | 130,479,043.00 | 134,188,984.00 | 79,444,564.00 | 100,579,807.00 | 170,402,923.00 | 391,288,646.00 | 483,355,853.00 | -186,793,986.00 | 473,148,905.00 | 407,062,124.00 | -409,891,447.00 | 340,618,807.00 | 528,991,196.00 | ||
| EBITDA ratio | (0.14%) | (0.33%) | (0.37%) | (0.35%) | (0.37%) | (0.32%) | (0.24%) | (0.24%) | (0.25%) | (0.31%) | (0.23%) | (0.17%) | (0.17%) | (0.17%) | (0.18%) | (0.19%) | (0.20%) | ||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 5,908,036.00 | 54,079,271.00 | 108,996,741.00 | 145,874,112.00 | 113,648,093.00 | 105,206,801.00 | 44,217,314.00 | 53,994,909.00 | 76,372,717.00 | 257,331,724.00 | 333,888,560.00 | -322,658,736.43 | 326,774,243.00 | 241,123,498.00 | -591,985,408.05 | 189,352,499.00 | 290,357,789.00 | ||
| Income Before Tax Ratio | (0.06%) | (0.27%) | (0.34%) | (0.31%) | (0.32%) | (0.25%) | (0.12%) | (0.12%) | (0.11%) | (0.20%) | (0.16%) | (-0.12%) | (0.12%) | (0.10%) | (-0.24%) | (0.08%) | (0.11%) | ||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 236,307.00 | 8,605,910.00 | 15,930,597.00 | 21,154,008.00 | 18,176,537.00 | 15,702,907.00 | 5,621,871.00 | 8,127,036.00 | 10,816,544.00 | 35,205,639.00 | 49,090,952.00 | 37,273,603.00 | 33,740,551.00 | 35,352,666.00 | 17,607,534.00 | -11,469,920.64 | 55,949,057.00 | ||
| Net Income | |||||||||||||||||||
| Net Income | 5,364,892.00
+0% |
45,698,953.00
+752% |
90,670,604.00
+98% |
123,136,915.00
+36% |
95,233,596.00
-23% |
88,505,120.00
-7% |
38,367,911.00
-57% |
45,707,273.00
+19% |
64,899,360.00
+42% |
221,958,231.00
+242% |
284,814,664.00
+28% |
-359,976,337.07
-226% |
292,829,529.00
-181% |
209,369,531.00
-29% |
-296,913,080.60
-242% |
204,607,567.00
-169% |
231,869,165.00
+13% |
||
| Net Income Ratio | (0.06%) | (0.23%) | (0.28%) | (0.27%) | (0.27%) | (0.21%) | (0.11%) | (0.10%) | (0.09%) | (0.17%) | (0.14%) | (-0.13%) | (0.11%) | (0.09%) | (-0.12%) | (0.08%) | (0.09%) | ||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.57 | 0.22 | 0.16 | 0.21 | 0.13 | 0.11 | 0.05 | 0.06 | 0.08 | 0.19 | 0.24 | -0.30 | 0.25 | 0.18 | -0.25 | 0.17 | 0.19 | ||
| Diluted EPS | 0.57 | 0.22 | 0.16 | 0.21 | 0.13 | 0.11 | 0.05 | 0.06 | 0.08 | 0.19 | 0.24 | -0.30 | 0.25 | 0.18 | -0.25 | 0.17 | 0.19 | ||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 9,368,544.00 | 210,503,052.00 | 582,882,459.00 | 585,651,183.00 | 733,048,079.00 | 780,927,538.00 | 767,358,228.00 | 761,787,896.00 | 811,242,005.00 | 1,168,201,221.00 | 1,186,727,767.00 | 1,189,712,382.00 | 1,189,712,382.00 | 1,189,712,382.00 | 1,189,712,382.00 | 1,189,712,382.00 | 1,220,364,028.00 | ||
| Diluted Share Outstanding | 9,368,544.00 | 210,503,052.00 | 582,882,459.00 | 585,651,183.00 | 733,048,079.00 | 780,927,538.00 | 767,358,228.00 | 761,787,896.00 | 811,242,005.00 | 1,168,201,221.00 | 1,186,727,767.00 | 1,199,921,124.00 | 1,189,712,382.00 | 1,189,712,382.00 | 1,189,712,382.00 | 1,189,712,382.00 | 1,220,364,028.00 | ||